Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Platelet-Rich Plasma treatment helps hair regrowth in people with mild Alopecia Areata, improving their quality of life with minimal side effects.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Children with alopecia areata often have low vitamin D, especially if they have darker skin, it's not summer, or they're not White.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

High-resolution MRI can distinguish between tertiary androgenetic alopecia and severe alopecia areata by measuring scalp and tissue thickness and hair follicle depth.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Ayurvedic treatment significantly reduced hair loss and improved hair quality in a 30-year-old male.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.